• nPEC Enables Accurate Dual-Loaded Liposome Encapsulation Ass

  2026-05-26

  This study introduces and validates nanoparticle exclusion chromatography (nPEC) as a universally applicable, accurate method for determining encapsulation efficiency in dual-loaded liposomes containing both hydrophilic and lipophilic drugs. The findings establish nPEC as a preferred analytical tool for complex co-encapsulated formulations, facilitating advances in combination drug delivery and antiviral research.

• Norovirus Exploits NINJ1 and Caspase-3 for Selective Protein

  2026-05-25

  Song et al. reveal that murine norovirus specifically hijacks the host protein NINJ1 to enable selective secretion of the viral NS1 protein, a process dependent on caspase-3-mediated cleavage. This discovery redefines the intersection of viral immune evasion and programmed cell death, opening new avenues for apoptosis research and the study of host-pathogen interactions.

• Iptacopan (LNP023): Transforming Alternative Complement Rese

  2026-05-25

  Explore how Iptacopan (LNP023), a potent oral inhibitor of complement factor B, is reshaping mechanistic understanding and translational strategies in alternative complement pathway modulation. This thought-leadership article blends detailed mechanistic insight, literature-backed protocols, and strategic guidance for researchers, reflecting on clinical breakthroughs in paroxysmal nocturnal hemoglobinuria (PNH) and offering actionable recommendations for experimental design. Learn how APExBIO’s Iptacopan sets a new benchmark for complement activation research, with critical appraisal of its selectivity, translational value, and future directions.

• Bafilomycin C1: Precision V-ATPase Inhibition for Autophagy

  2026-05-24

  Bafilomycin C1, a gold-standard vacuolar H+-ATPases inhibitor from APExBIO, empowers high-fidelity assays in autophagy, apoptosis, and intracellular pH regulation. This article translates bench protocols and troubleshooting into actionable guidance, spotlighting workflow enhancements and innovations for rigorous phenotypic screens.

• ZCL278 (SKU A8300): Reliable Cdc42 Inhibition for Cell Assay

  2026-05-23

  This article provides a scenario-driven exploration of ZCL278 (SKU A8300), a selective Cdc42 inhibitor, detailing its application in cell viability, proliferation, and cytotoxicity workflows. Drawing on peer-reviewed data and real-world lab challenges, it demonstrates how ZCL278 ensures reproducible, high-sensitivity results for biomedical researchers. The guide offers actionable protocol advice and vendor comparisons, underlining ZCL278’s value for advanced cell signaling studies.

• Ciclesonide in Respiratory Research: Potency, Protocols & ER

  2026-05-22

  Ciclesonide’s targeted prodrug activation enables precise, potent anti-inflammatory assays in asthma and allergic rhinitis models. Learn how recent ERAD-hijacking technologies and practical workflow enhancements can elevate glucocorticoid receptor research with APExBIO’s high-purity compound.

• NMDA in Translational Neurodegeneration: From Mechanism to M

  2026-05-22

  This thought-leadership article explores how NMDA (N-Methyl-D-aspartic acid), a potent and specific NMDA receptor agonist, enables advanced translational research in neurodegenerative disease modeling and excitotoxicity. We dissect mechanistic underpinnings, integrate groundbreaking findings from glaucoma research, and offer actionable guidance for maximizing experimental rigor and impact with APExBIO's NMDA.

• USP36-Snail1 Axis Drives Ribosome Biogenesis Under Ribotoxic

  2026-05-21

  This study uncovers how the deubiquitinase USP36 stabilizes the transcription factor Snail1 within the nucleolus, promoting ribosome biogenesis and solid tumor cell survival during ribotoxic stress. By elucidating the JNK-USP36-Snail1 signaling pathway, the authors provide a mechanistic rationale for targeting this axis to enhance the effectiveness of ribosome-inhibiting therapies in solid tumors.

• Hexetidine (NSC-17764): Protocols & Synergy for Oral Infecti

  2026-05-21

  Hexetidine (NSC-17764) delivers broad-spectrum, strain-specific antimicrobial power for oral infection research—especially when paired with copper for synergistic effects. This guide distills reference-backed protocols, advanced workflow enhancements, and troubleshooting insights to optimize both biofilm inhibition and planktonic assays.

• Nile Red for Quantitative Lipid Storage Dynamics: Beyond Sta

  2026-05-20

  Explore how Nile Red (Nile blue oxazone) advances quantitative lipid storage dynamics analysis in cell biology. This article reveals unique assay insights, integrating recent mechanistic research for deeper, more reproducible lipid metabolism studies.

• ICG001 (SKU A8217): Reliable Wnt/β-Catenin Pathway Inhibitio

  2026-05-20

  This article guides biomedical researchers through real-world challenges in cell viability and fibrosis assays, demonstrating how ICG001 (SKU A8217) enables precise, reproducible Wnt/β-catenin pathway inhibition. Drawing on peer-reviewed data and hands-on protocol tips, the piece details how APExBIO’s ICG001 supports robust experimental outcomes in cancer and fibrosis models.

• H 89 2HCl: Advanced Dissection of cAMP/PKA Signaling in Neur

  2026-05-19

  Explore how H 89 2HCl enables next-level analysis of cAMP/PKA signaling in neuroinflammatory and mechanotransduction pathways. This article uniquely integrates recent mechanistic findings with advanced assay guidance for researchers.

• Grazoprevir/Elbasvir Therapy: Advances in HCV Genotype 1 & 4

  2026-05-19

  The reference review details the clinical development and impact of the grazoprevir (MK-5172 hydrate) and elbasvir combination for hepatitis C virus (HCV) infection, emphasizing its high efficacy, safety, and simplified regimens for genotypes 1 and 4. These findings highlight the practical advantages of dual direct-acting antiviral therapy, especially for complex patient subgroups.

• Optimizing Cell Cytotoxicity Measurement with LDH Cytotoxici

  2026-05-18

  This article presents a scenario-driven exploration of laboratory challenges in cell cytotoxicity measurement and demonstrates how the LDH Cytotoxicity Assay Kit (SKU K2228) from APExBIO ensures reliable, reproducible results. Integrating literature evidence and practical workflow advice, the discussion guides biomedical researchers and lab professionals to select and implement robust apoptosis detection and cell damage quantification protocols.

• PPP1R3G/PP1γ-Driven RIPK1 Dephosphorylation Regulates Cell D

  2026-05-18

  This study defines a critical mechanism by which PPP1R3G and PP1γ regulate RIPK1 activation through targeted dephosphorylation, directly impacting apoptosis and necroptosis. These findings clarify key control points in cell death relevant to inflammation and cancer biology, with implications for experimental design using pathway-selective inhibitors.

453 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page